New Paradigm Therapeutics, Alize Pharma deal

Alize received exclusive, worldwide rights from New Paradigm Therapeutics to develop and commercialize peptides derived from a fragment of insulin-like growth factor (IGF) binding protein 2 (IGFBP2) ...